2021-01-23 02:36:08 GMT2021-01-23 10:36:08(Beijing Time) Xinhua English
BRASILIA, Jan. 22 (Xinhua) Brazil s Health Regulatory Agency (Anvisa) unanimously approved on Friday the emergency use of another 4.8 million doses of the CoronaVac vaccine against COVID-19.
The request was made by the Sao Paulo-based Butantan Institute on Monday, a day after Anvisa authorized the use of the first batch of 6 million doses of CoronaVac, which kicked off a countrywide COVID-19 vaccination process.
The vaccines were developed by Chinese pharmaceutical firm Sinovac Biotech in partnership with the Butantan Institute.
Anvisa said it considers CoronaVac a safe, quality and effective vaccine, noting that its application in the first week of immunization has not presented any problems.
RIO DE JANEIRO, Jan. 20 (Xinhua) Brazil on Wednesday reported more 1,340 deaths from COVID-19 in a day, the second highest daily count since Aug. 19, the Hea
Brazil registered more that 1,340 coronavirus deaths in the last 24 hours, marking the second highest single-day spike since August 19, 2020, the Health Ministry said.The highest single-day death toll was 1,524, registered on January 7, Xinhua .
Brazil official: China vaccine capable of preventing disease, death chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.